top of page


12:00 p.m. - 2:00 p.m.


The Science & Innovation Symposium is part of the in-person event held at Staglin Family Vineyard and melds the expertise of its guest speakers with its welcoming and familial atmosphere to boost knowledge and hope for all who attend.


Susan Monarez, PhD

Deputy Director, Advanced Research Projects Agency for Health (ARPA-H)

Dr. Susan Coller Monarez is a globally recognized leader in health innovation, currently serving as the Deputy Director at the Advanced Research Projects Agency for Health (ARPA-H). With over twenty years of experience, she has driven biomedical and health breakthroughs to deliver transformative and equitable health solutions. Dr. Monarez previously founded the Center for Innovation at the Health Resources and Services Administration and led national health security initiatives at the White House as the Assistant Director for National Health Security and International Affairs and the Director of Medical Preparedness Policy on the National Security Council.


Her extensive career includes leadership roles at the Homeland Security Advanced Research Projects Agency (HSARPA) and the Biomedical Advanced Research Projects Agency (BARDA). Dr. Monarez has been a key figure on numerous advisory panels, including the National Academies of Science and the National Science Advisory Board for Biosecurity, and has represented the U.S. in international health initiatives with the European Union, Canada, France, the Netherlands, and the United Kingdom. She is also a former AAAS Science and Technology Policy fellow and a research scientist in microbiology and immunology at the University of Wisconsin and Stanford University School of Medicine.

One Mind Rising Star Awards Logo_transparent.png

The 2024 One Mind Rising Star Award winners will be at the Science & Innovation Symposium to present their awarded research projects and participate in a Q&A session with those in attendance. 

One Mind Accelerator Logo_All Black_Stacked.png

The One Mind Accelerator backs visionary founders of early-stage startups with the network, education, and capital to rapidly build category-defining companies that improve the lives of people living with mental illness.
The One Mind Accelerator was launched in 2023, with an inaugural cohort of 11 companies. This year, 10 startups were selected from 181 applications for the 2024 session. Each company will receive a  $100,000 investment from One Mind and will participate in 9 weeks of intensive programming designed to help founders rapidly take their companies to the next level.



Deep Science & Tech


with the 2024 One Mind Accelerator Startups

Innovation Spotlight Speakers have not yet been announced.

bottom of page